Home/Filings/4/0001209191-23-057712
4//SEC Filing

Conner Edward R. 4

Accession 0001209191-23-057712

CIK 0001923840other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:03 PM ET

Size

9.4 KB

Accession

0001209191-23-057712

Insider Transaction Report

Form 4
Period: 2023-12-05
Conner Edward R.
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-05$4.20/sh+4,790$20,1184,790 total
  • Sale

    Common Stock

    2023-12-05$10.03/sh4,790$48,0620 total
  • Exercise/Conversion

    Employee Option Grant (right to buy)

    2023-12-05+4,790378,498 total
    Exercise: $4.20Exp: 2032-07-27Common Stock (4,790 underlying)
Footnotes (3)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]25% of the total shares vested on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0001691265

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:03 PM ET
Size
9.4 KB